{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T03:22:09Z","timestamp":1776309729908,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr Pathol"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1007\/s12022-011-9151-1","type":"journal-article","created":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T17:51:03Z","timestamp":1299001863000},"page":"44-52","source":"Crossref","is-referenced-by-count":28,"title":["Identification of De Novo Germline Mutations in the HRPT2 Gene in Two Apparently Sporadic Cases with Challenging Parathyroid Tumor Diagnoses"],"prefix":"10.1007","volume":"22","author":[{"given":"Branca Maria","family":"Cavaco","sequence":"first","affiliation":[]},{"given":"Rita","family":"Santos","sequence":"additional","affiliation":[]},{"given":"Ana","family":"F\u00e9lix","sequence":"additional","affiliation":[]},{"given":"Davide","family":"Carvalho","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 Manuel","family":"Lopes","sequence":"additional","affiliation":[]},{"given":"Rita","family":"Domingues","sequence":"additional","affiliation":[]},{"given":"Marta","family":"Sirgado","sequence":"additional","affiliation":[]},{"given":"N\u00e1dia","family":"Rei","sequence":"additional","affiliation":[]},{"given":"Fernando","family":"Fonseca","sequence":"additional","affiliation":[]},{"given":"Jorge Rosa","family":"Santos","sequence":"additional","affiliation":[]},{"given":"Lu\u00eds","family":"Sobrinho","sequence":"additional","affiliation":[]},{"given":"Valeriano","family":"Leite","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2011,3,1]]},"reference":[{"key":"9151_CR1","volume-title":"World Health Organization. Classification of Tumors Pathology and Genetics of Tumors of Endocrine Organs","year":"2004","unstructured":"DeLellis RA, Lloyd RV, Heitz PU editors. World Health Organization. Classification of Tumors Pathology and Genetics of Tumors of Endocrine Organs. IARC Press: Lyon 2004."},{"key":"9151_CR2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s12022-008-9050-2","volume":"19","author":"RA DeLellis","year":"2008","unstructured":"DeLellis RA. Challenging lesions in the differential diagnosis of endocrine tumors: parathyroid carcinoma. Endocr Pathol 19:221\u2013225, 2008.","journal-title":"Endocr Pathol"},{"key":"9151_CR3","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.amjoto.2008.05.006","volume":"30","author":"G Schoretsanitis","year":"2009","unstructured":"Schoretsanitis G, Daskalakis M, Melissas J, Tsiftsis DD. Parathyroid carcinoma: clinical presentation and management. Am J Otolaryngol 30:277\u2013280, 2009.","journal-title":"Am J Otolaryngol"},{"key":"9151_CR4","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1365-2559.2010.03515.x","volume":"56","author":"SJ Johnson","year":"2010","unstructured":"Johnson SJ. Changing clinicopathological practice in parathyroid disease. Histopathology 56:835\u2013851, 2010.","journal-title":"Histopathology"},{"key":"9151_CR5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2796.2004.01428.x","volume":"257","author":"T Carling","year":"2005","unstructured":"Carling T, Udelsman R. Parathyroid surgery in familial hyperparathyroid disorders. J Intern Med 257:27\u201337, 2005.","journal-title":"J Intern Med"},{"key":"9151_CR6","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1007\/s00268-009-9999-0","volume":"33","author":"T Okamoto","year":"2009","unstructured":"Okamoto T, Iihara M, Obara T, Tsukada T. Parathyroid carcinoma: etiology, diagnosis, and treatment. World J Surg 33:2343\u20132354, 2009.","journal-title":"World J Surg"},{"key":"9151_CR7","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/jmg.40.9.657","volume":"40","author":"VM Howell","year":"2003","unstructured":"Howell VM, Haven CJ, Kahnoski K, Khoo SK, Petillo D, Chen J, Fleuren GJ, Robinson BG, Delbridge LW, Philips J, Nelson AE, Krause U, Hammje K, Dralle H, Hoang-Vu C, Gimm O, Marsh DJ, Morreau H, Teh BT. HRPT2 mutations are associated with malignancy in sporadic parathyroid tumors. J Med Genet 40:657\u2013663, 2003.","journal-title":"J Med Genet"},{"key":"9151_CR8","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1056\/NEJMoa031237","volume":"349","author":"TM Shattuck","year":"2003","unstructured":"Shattuck TM, V\u00e4lim\u00e4ki S, Obara T, Gaz RD, Clark OH, Shoback D, Wierman ME, Tojo K, Robbins CM, Carpten JD, Farnebo LO, Larsson C, Arnold A. Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med 349:1722\u20131729, 2003.","journal-title":"N Engl J Med"},{"key":"9151_CR9","doi-asserted-by":"crossref","first-page":"5583","DOI":"10.1210\/jc.2004-0294","volume":"89","author":"F Cetani","year":"2004","unstructured":"Cetani F, Pardi E, Borsari S, Viacava P, Dipollina G, Cianferotti L, Ambrogini E, Gazzerro E, Colussi G, Berti P, Miccoli P, Pinchera A, Marcocci C. Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors. J Clin Endocrinol Metab 89:5583\u20135591, 2004.","journal-title":"J Clin Endocrinol Metab"},{"key":"9151_CR10","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1677\/ERC-08-0066","volume":"15","author":"G Masi","year":"2008","unstructured":"Masi G, Barzon L, Iacobone M, Viel G, Porzionato A, Macchi V, De Caro R, Favia G, Pal\u00f9 G. Clinical, genetic, and histopathologic investigation of CDC73-related familial hyperparathyroidism. Endocr Relat Cancer 15:1115\u20131126, 2008.","journal-title":"Endocr Relat Cancer"},{"key":"9151_CR11","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/humu.21188","volume":"31","author":"PJ Newey","year":"2010","unstructured":"Newey PJ, Bowl MR, Cranston T, Thakker RV. Cell division cycle protein 73 homolog (CDC73) mutations in the hyperparathyroidism-jaw tumor syndrome (HPT-JT) and parathyroid tumors. Hum Mutat 31:295\u2013307, 2010.","journal-title":"Hum Mutat"},{"key":"9151_CR12","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/qjmed\/94.4.213","volume":"94","author":"BM Cavaco","year":"2001","unstructured":"Cavaco BM, Barros L, Pannett AA, Ruas L, Carvalheiro M, Ruas MM, Krausz T, Santos MA, Sobrinho LG, Leite V, Thakker RV. The hyperparathyroidism-jaw tumor syndrome in a Portuguese kindred. Q J Med 94:213\u2013222, 2001.","journal-title":"Q J Med"},{"key":"9151_CR13","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1210\/jc.2003-031016","volume":"89","author":"BM Cavaco","year":"2004","unstructured":"Cavaco BM, Guerra L, Bradley KJ, Carvalho D, Harding B, Oliveira A, Santos MA, Sobrinho LG, Thakker RV, Leite V. Hyperparathyroidism-jaw tumor syndrome in Roma families from Portugal is due to a founder mutation of the HRPT2 gene. J Clin Endocrinol Metab 89:1747\u20131752, 2004.","journal-title":"J Clin Endocrinol Metab"},{"key":"9151_CR14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1365-2796.2004.01421.x","volume":"257","author":"KJ Bradley","year":"2005","unstructured":"Bradley KJ, Hobbs MR, Buley ID, Carpten JD, Cavaco BM, Fares JE, Laidler P, Manek S, Robbins CM, Salti IS, Thompson NW, Jackson CE, Thakker RV. Uterine tumors are a phenotypic manifestation of the hyperparathyroidism-jaw tumor syndrome. J Intern Med 257:18\u201326, 2005.","journal-title":"J Intern Med"},{"key":"9151_CR15","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1046\/j.1365-2265.2003.01765.x","volume":"58","author":"AA Pannett","year":"2003","unstructured":"Pannett AA, Kennedy AM, Turner JJ, Forbes SA, Cavaco BM, Bassett JH, Cianferotti L, Harding B, Shine B, Flinter F. Multiple endocrine neoplasia type 1 (MEN1) germline mutations in familial isolated primary hyperparathyroidism. Clin Endocrinol (Oxf) 58:639\u2013646, 2003.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9151_CR16","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/humu.20067","volume":"24","author":"S Pidasheva","year":"2004","unstructured":"Pidasheva S, D'Souza-Li L, Canaff L, Cole DE, Hendy GN. CASRdb: calcium-sensing receptor locus-specific database for mutations causing familial (benign) hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia. Hum Mutat 24:107\u2013111, 2004.","journal-title":"Hum Mutat"},{"key":"9151_CR17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/jmg.2003.016725","volume":"41","author":"J Warner","year":"2004","unstructured":"Warner J, Epstein M, Sweet A, Singh D, Burgess J, Stranks S, Hill P, Perry-Keene D, Learoyd D, Robinson B. Genetic testing in familial isolated hyperparathyroidism: unexpected results and their implications. J Med Genet 41:155\u2013160, 2004.","journal-title":"J Med Genet"},{"key":"9151_CR18","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ng1048","volume":"32","author":"JD Carpten","year":"2002","unstructured":"Carpten JD, Robbins CM, Villablanca A, Forsberg L, Presciuttini S, Bailey-Wilson J, Simonds WF, Gillanders EM, Kennedy AM, Chen JD, Agarwal SK, Sood R, Jones MP, Moses TY, Haven C, Petillo D, Leotlela PD, Harding B, Cameron D, Pannett AA, H\u00f6\u00f6g A, Heath H 3rd, James-Newton LA, Robinson B, Zarbo RJ, Cavaco BM, Wassif W, Perrier ND, Rosen IB, Kristoffersson U, Turnpenny PD, Farnebo LO, Besser GM, Jackson CE, Morreau H, Trent JM, Thakker RV, Marx SJ, Teh BT, Larsson C, Hobbs MR. HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet 32:676\u2013680, 2002.","journal-title":"Nat Genet"},{"key":"9151_CR19","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/sj.onc.1208274","volume":"24","author":"GE Woodard","year":"2005","unstructured":"Woodard GE, Lin L, Zhang JH, Agarwal SK, Marx SJ, Simonds WF. Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1\/PRAD1 expression. Oncogene 24:1272\u20131276, 2005.","journal-title":"Oncogene"},{"key":"9151_CR20","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/nar\/gkp991","volume":"38","author":"YJ Yang","year":"2010","unstructured":"Yang YJ, Han JW, Youn HD, Cho EJ. The tumor suppressor, parafibromin, mediates histone H3 K9 methylation for cyclin D1 repression. Nucleic Acids Res 38:382\u2013390, 2010.","journal-title":"Nucleic Acids Res"},{"key":"9151_CR21","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1365-2265.2006.02460.x","volume":"64","author":"KJ Bradley","year":"2006","unstructured":"Bradley KJ, Cavaco BM, Bowl MR, Harding B, Cranston T, Fratter C, Besser GM, Concei\u00e7\u00e3o Pereira M, Davie MW, Dudley N, Leite V, Sadler GP, Seller A, Thakker RV. Parafibromin mutations in hereditary hyperparathyroidism syndromes and parathyroid tumors. Clin Endocrinol Oxf 64:299\u2013306, 2006.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9151_CR22","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1073\/pnas.68.4.820","volume":"68","author":"AG Knudson Jr","year":"1971","unstructured":"Knudson AG Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 68:820\u2013823, 1971.","journal-title":"Proc Natl Acad Sci USA"},{"key":"9151_CR23","doi-asserted-by":"crossref","first-page":"6629","DOI":"10.1158\/1078-0432.CCR-04-0493","volume":"10","author":"MH Tan","year":"2004","unstructured":"Tan MH, Morrison C, Wang P, Yang X, Haven CJ, Zhang C, Zhao P, Tretiakova MS, Korpi-Hyovalti E, Burgess JR, Soo KC, Cheah WK, Cao B, Resau J, Morreau H, Teh BT. Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma. Clin Cancer Res 10:6629\u20136637, 2004.","journal-title":"Clin Cancer Res"},{"key":"9151_CR24","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1097\/01.pas.0000209827.39477.4f","volume":"30","author":"AJ Gill","year":"2006","unstructured":"Gill AJ, Clarkson A, Gimm O, Keil J, Dralle H, Howell VM, Marsh DJ. Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias. Am J Surg Pathol 30:1140\u20131149, 2006.","journal-title":"Am J Surg Pathol"},{"key":"9151_CR25","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1677\/ERC-07-0021","volume":"14","author":"CC Juhlin","year":"2007","unstructured":"Juhlin CC, Villablanca A, Sandelin K, Haglund F, Nordenstr\u00f6m J, Forsberg L, Br\u00e4nstr\u00f6m R, Obara T, Arnold A, Larsson C, H\u00f6\u00f6g A. Parafibromin immunoreactivity: its use as an additional diagnostic marker for parathyroid tumor classification. Endocr Relat Cancer 14: 501\u2013512, 2007","journal-title":"Endocr Relat Cancer"},{"key":"9151_CR26","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1530\/EJE-06-0720","volume":"156","author":"F Cetani","year":"2007","unstructured":"Cetani F, Ambrogini E, Viacava P, Pardi E, Fanelli G, Naccarato AG, Borsari S, Lemmi M, Berti P, Miccoli P, Pinchera A, Marcocci C. Should parafibromin staining replace HRTP2 gene analysis as an additional tool for histologic diagnosis of parathyroid carcinoma? Eur J Endocrinol 156:547\u2013554, 2007.","journal-title":"Eur J Endocrinol"},{"key":"9151_CR27","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/cncr.24037","volume":"115","author":"GG Fernandez-Ranvier","year":"2009","unstructured":"Fernandez-Ranvier GG, Khanafshar E, Tacha D, Wong M, Kebebew E, Duh QY, Clark OH Defining a molecular phenotype for benign and malignant parathyroid tumors. Cancer 115:334\u2013344, 2009.","journal-title":"Cancer"},{"key":"9151_CR28","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1210\/jc.2008-1740","volume":"94","author":"VM Howell","year":"2009","unstructured":"Howell VM, Gill A, Clarkson A, Nelson AE, Dunne R, Delbridge LW, Robinson BG, Teh BT, Gimm O, Marsh DJ. Accuracy of combined protein gene product 9.5 and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinoma. J Clin Endocrinol Metab 94:434\u2013441, 2009.","journal-title":"J Clin Endocrinol Metab"},{"key":"9151_CR29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-2265.2006.02534.x","volume":"65","author":"N Mizusawa","year":"2006","unstructured":"Mizusawa N, Uchino S, Iwata T, Tsuyuguchi M, Suzuki Y, Mizukoshi T, Yamashita Y, Sakurai A, Suzuki S, Beniko M, Tahara H, Fujisawa M, Kamata N, Fujisawa K, Yashiro T, Nagao D, Golam HM, Sano T, Noguchi S, Yoshimoto K. Genetic analyses in patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumor syndrome. Clin Endocrinol (Oxf) 65:9\u201316, 2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9151_CR30","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.surg.2008.08.008","volume":"144","author":"V Guarnieri","year":"2008","unstructured":"Guarnieri V, Bisceglia M, Bonfitto N, Cetani F, Marcocci C, Minisola S, Battista C, Chiodini I, Cole DE, Scillitani A. Familial hyperparathyroidism: surgical outcome after 30\u00a0years of follow-up in three families with germline HRPT2 mutations. Surgery 144:839\u2013840, 2008.","journal-title":"Surgery"},{"key":"9151_CR31","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1677\/ERC-06-0092","volume":"14","author":"F Cetani","year":"2007","unstructured":"Cetani F, Pardi E, Ambrogini E, Viacava P, Borsari S, Lemmi M, Cianferotti L, Miccoli P, Pinchera A, Arnold A, Marcocci C. Different somatic alterations of the HRPT2 gene in a patient with recurrent sporadic primary hyperparathyroidism carrying an HRPT2 germline mutation. Endocr Relat Cancer 14:493\u2013499, 2007.","journal-title":"Endocr Relat Cancer"},{"key":"9151_CR32","first-page":"456","volume":"113","author":"MS Sokol","year":"1993","unstructured":"Sokol MS, Kavolius J, Schaaf M, D'Avis J. Recurrent hyperparathyroidism from benign neoplastic seeding: a review with recommendations for management. Surgery 113:456\u2013461, 1993.","journal-title":"Surgery"},{"key":"9151_CR33","doi-asserted-by":"crossref","first-page":"7405","DOI":"10.1158\/0008-5472.CAN-04-2063","volume":"64","author":"CJ Haven","year":"2004","unstructured":"Haven CJ, Howell VM, Eilers PH, Dunne R, Takahashi M, van Puijenbroek M, Furge K, Kievit J, Tan MH, Fleuren GJ, Robinson BG, Delbridge LW, Philips J, Nelson AE, Krause U, Dralle H, Hoang-Vu C, Gimm O, Morreau H, Marsh DJ, Teh BT. Gene expression of parathyroid tumors: molecular subclassification and identification of the potential malignant phenotype. Cancer Res 64:7405\u20137411, 2004.","journal-title":"Cancer Res"},{"key":"9151_CR34","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1677\/erc.1.01058","volume":"13","author":"C Juhlin","year":"2006","unstructured":"Juhlin C, Larsson C, Yakoleva T, Leibiger I, Leibiger B, Alimov A, Weber G, H\u00f6\u00f6g A, Villablanca A. Loss of parafibromin expression in a subset of parathyroid adenomas. Endocr Relat Cancer 13:509\u2013523, 2006.","journal-title":"Endocr Relat Cancer"},{"key":"9151_CR35","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/(SICI)1097-0142(19990801)86:3<538::AID-CNCR25>3.0.CO;2-K","volume":"86","author":"SA Hundahl","year":"1999","unstructured":"Hundahl SA, Fleming ID, Fremgen AM, Menck HR. Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. between 1985\u20131995: a National Cancer Data Base Report. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 86:538\u2013544,1999.","journal-title":"Cancer"},{"key":"9151_CR36","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1007\/BF00353773","volume":"18","author":"K Sandelin","year":"1994","unstructured":"Sandelin K, Tullgren O, Farnebo LO. Clinical course of metastatic parathyroid cancer. World J Surg 18:594\u2013598, 1994.","journal-title":"World J Surg"}],"container-title":["Endocrine Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-011-9151-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12022-011-9151-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-011-9151-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T02:01:03Z","timestamp":1559440863000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12022-011-9151-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["9151"],"URL":"https:\/\/doi.org\/10.1007\/s12022-011-9151-1","relation":{},"ISSN":["1046-3976","1559-0097"],"issn-type":[{"value":"1046-3976","type":"print"},{"value":"1559-0097","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}